BioNTech SE - ADR vs Wheaton Precious Metals Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Wheaton Precious Metals Corp trades at $136.29 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 2.6× BioNTech SE - ADR's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | WPM | |
|---|---|---|
Market Cap | $23.31B | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $119.34 | $165.72 |
52-Week Low | $83.89 | $91.02 |
Enterprise Value | $6.60B | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →